Ultragenyx Faces Lawsuit Over Alleged Unjust Use of Henrietta Lacks' Cells - Ultragenyx Pharmaceutical (NASDAQ:RARE)

The estate of Henrietta Lacks can proceed with a lawsuit against Ultragenyx Pharmaceutical over the use of HeLa cells taken without her consent in the 1950s. A Maryland federal court ruled against Ultragenyx's motion to dismiss, allowing the case to continue.

Related Keywords

Maryland ,United States ,Baltimore ,Christopher Ayers ,Henrietta Lacks ,Seeger Weiss ,Deborah Boardman ,Christopher Seeger ,Reuters ,Thermo Fisher ,Judge Boardman ,Thermo Fisher Scientificinc ,